Vascular Biogenics Backtested Returns
Macroaxis considers Vascular Biogenics to be relatively risky. Vascular Biogenics
owns Efficiency Ratio (i.e. Sharpe Ratio) of -0.0808 which indicates Vascular Biogenics
had -0.0808% of return per unit of risk over the last 1 month. Macroaxis philosophy towards measuring risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators
. Vascular Biogenics Ltd exposes twenty-one different technical indicators
which can help you to evaluate volatility that cannot be diversified away. Please be advised to validate Vascular Biogenics Coefficient Of Variation
of (1,007) and Risk Adjusted Performance of (0.017618) to confirm risk estimate we provide. Macroaxis gives Vascular Biogenics performance score of 0 on a scale of 0 to 100. The entity has beta of 1.4065 which indicates as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Vascular Biogenics will likely underperform.. Even though it is essential to pay attention to Vascular Biogenics current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Vascular Biogenics Ltd exposes twenty-one different technical indicators which can help you to evaluate its performance. Vascular Biogenics has expected return of -0.2842%. Please be advised to validate Vascular Biogenics Jensen Alpha and Semi Variance to decide if Vascular Biogenics past performance will be repeated at some point in the near future.
|15 days auto-correlation||(0.41) |
Modest reverse predictability
Vascular Biogenics Ltd has modest reverse predictability. Overlapping area represents the amount of predictability between Vascular Biogenics time series from September 23, 2017 to October 8, 2017 and October 8, 2017 to October 23, 2017. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vascular Biogenics price movement. The serial correlation of -0.41 indicates that just about 41.0% of current Vascular Biogenics price fluctuation can be explain by its past prices. Given that Vascular Biogenics Ltd has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Vascular Biogenics for similar time interval.
|Correlation Coefficient|| -0.41|
|Spearman Rank Test|| 0.26|
|Price Variance|| 0.04|
|Lagged Price Variance|| 0.03|
Vascular Biogenics Lagged Returns